China Pharma Holdings (CPHI) Common Equity (2010 - 2026)
China Pharma Holdings (CPHI) posted Common Equity of $37.0 million for Q1 2026, up 20468.99% on a QoQ basis from $180000.0 in Q4 2025, and up 431.21% year-over-year from $7.0 million in Q1 2025.
China Pharma Holdings (CPHI) Common Equity (2010 - 2026) Analysis & Trends
China Pharma Holdings' Common Equity history runs 17 years deep, the most recent figure standing at $37.0 million for Q1 2026.
- Quarterly Common Equity rose 431.21% year-over-year to $37.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.0 million (up 431.21% YoY) and the FY2025 annual result came in at $180000.0, down 97.68% from the prior year.
- Common Equity was $37.0 million for Q1 2026 at China Pharma Holdings, up from $180000.0 in the prior quarter.
- Across five years, Common Equity topped out at $37.0 million in Q1 2026 and bottomed at $180000.0 in Q3 2025.
- A 5-year average of $7.1 million and a median of $6.1 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2025 — Common Equity sank 97.68% — and 2026, when it soared 431.21%.
- China Pharma Holdings' Common Equity stood at $4.3 million in 2022, then surged by 73.77% to $7.5 million in 2023, then gained by 3.93% to $7.7 million in 2024, then sank by 97.68% to $180000.0 in 2025, then soared by 20468.99% to $37.0 million in 2026.
- Business Quant data shows CPHI's Common Equity at $37.0 million in Q1 2026, $180000.0 in Q4 2025, and $180000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | 37.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.02 Mn |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | 180,000.00 |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 6.97 Mn |
| Dec 31, 2024 | 7.75 Mn |
| Sep 30, 2024 | 6.53 Mn |
| Jun 30, 2024 | 7.41 Mn |
| Mar 31, 2024 | 8.29 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Sep 30, 2023 | 6.11 Mn |
| Jun 30, 2023 | 4.35 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 4.29 Mn |
| Sep 30, 2022 | 2.83 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 5.34 Mn |
| Dec 31, 2021 | 6.02 Mn |
| Sep 30, 2021 | 6.85 Mn |
| Jun 30, 2021 | 6.52 Mn |